SAN DIEGO & HAYWARD, Calif.– –Aug. 28, 2006 - Zogenix, Inc., a privately held pharmaceutical company focused on medicines to treat CNS disorders and pain, today announced that the company has raised $60 …
Top Stories
- How badly could a recession hurt cleantech? ...
- Google prepping special iPhone ads?
- Stock market swings wildly -- plunges, then ...
- Orkut on the iPhone — a Brazilian ...
- Will Condé Nast close Portfolio? Magazines stay ...
Recent Guest Columnists
- William Quigley
Remaining objective when fear is in the air - Todd Kimmel
What to expect from cleantech in the downturn - Lee Hower
Platforms and developers, part three: What platforms like Facebook can do to expand the developer ecosystem
Job Board
- Product Manager
at True Knowledge (Cambridge, Cambridgeshire, UK) - Interactive Production Designer
at EyeWonder, Inc (233 Peachtree Street Atlanta, GA 30303) - Alliance Marketing Consultant BP
at Sun Microsystems (MENLO PARK, CA) - More Jobs » | Post a Job »
Links
Venturebeat Writers
- Matt Marshall, Editor-in-Chief
- Dean Takahashi, Lead Writer, DigitalMedia
- Eric Eldon, Editor, DigitalMedia
- MG Siegler, Writer, DigitalMedia
- Anthony Ha, Writer, VentureBeat
- Chris Morrison, Writer, CleanTech
- For advertising, contact .
- Log in
Font Size
© 2004-2008(c) Matt Marshall. All rights reserved.Site produced by RubyRed Labs, Evan Levelle
powered by Wordpress
12:36 pm
VentureBeat » Life sciences briefing: Wednesday, Jan. 9, 2008 said:
[...] funding round back in Aug. 2006, and apparently has been quiet since then. Our coverage of them is here. Zogenix is developing a needle-free injection system for pain and CNS drugs, which it licensed [...]